Learn more

SEQUELLA INC

Overview
  • Total Patents
    32
About

SEQUELLA INC has a total of 32 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GRINDEKS JOINT STOCK COMPANY, EPIS SA and ERRANT GENE THERAPEUTICS LLC.

Patent filings per year

Chart showing SEQUELLA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bogatcheva Elena 11
#2 Protopopova Marina Nikolaevna 10
#3 Einck Leo 10
#4 Sacksteder Katherine 7
#5 Mulvey Matthew C 7
#6 Mccombs Candace 5
#7 Lakowicz Joseph R 3
#8 Protopopova Marina 3
#9 Gryczynski Zygmunt 3
#10 Abugo Omoefe 3

Latest patents

Publication Filing date Title
CA2825187A1 Improved methods and compositions for determining the pathogenic status of infectious agents
WO2009136965A1 Compositions and methods comprising capuramycin analogues
US2009047658A1 Methods and compositions for determining the pathogenic status of infectious agents
WO2006026404A2 Assay for detecting tuberculosis in nonhuman primates
US2006148904A1 Anti tubercular drug: compositions and methods
US7884097B2 Methods and compositions comprising diamines as new anti-tubercular therapeutics
AU2003228240A1 Methods of use and compositions for the diagnosis and treatment of infectious disease
CN101404986A Methods of use and compositions for the diagnosis and treatment of infectious disease
CA2485592A1 Anti tubercular drug: compositions and methods
WO0037114A2 Methods and compositions comprising monitoring devices